11 May 2016
What do you get from your subscription?
10 year forecasts
View 10 year forecasts across a number of indications and drugs in the CNS market, such as sales projections for Tecfidera’s and the impact this will have on competitors’ market share
Understand trends across the whole of the CNS market, such as the differences between the treatment of dysthymia, major depression and treatment-resistant major depression
Access our 10 year incident case forecasts for the CNS market, with insight into areas with a growing number of cases, such as Alzheimer’s, with western populations becoming increasingly older
Pipeline and marketed drugs
Analysis into CNS pipeline and marketed drugs, such as the neuropathic pain pipeline and recognize how these candidates fail to compare favorably on clinical and commercial attributes to the current market leaders